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Objectives: Stage 1 palliation of hypoplastic left heart syndrome requires the
interruption of whole-body perfusion. Delayed reflow in the cerebral circulation
secondary to prolonged elevation in vascular resistance occurs in neonates after
deep hypothermic circulatory arrest. We examined relative changes in cerebral and
somatic oxygenation with near-infrared spectroscopy while using a modified per-
fusion strategy that allowed continuous cerebral perfusion.
Methods: Nine neonates undergoing stage 1 palliation for hypoplastic left heart syn-
drome had regional tissue oxygenation continuously measured by frontal cerebral and
thoraco-lumbar (T10-L2) somatic (renal) reflectance oximetry probes (rSO2, INVOS;
Somanetics, Troy, Mich). Surgery was accomplished using cardiopulmonary bypass
with whole-body cooling (18°C-20°C) and regional cerebral perfusion through the
innominate artery at flow rates guided by estimated minimum flow requirements and
measured rSO2 during reconstruction of the aortic arch. Data were logged at
1-minute intervals and analyzed using repeated measures analysis of variance.
Results: A total of 3176 minutes of data were analyzed. Prebypass cerebral rSO2
was 65.4 8.9, and somatic rSO2 was 58.9 12.4 (P .001, cerebral vs somatic).
During regional cerebral perfusion, cerebral rSO2 was 80.7 8.6, and somatic rSO2
was 41.4  7.1 (P  .001). Postbypass cerebral rSO2 was 53.2  14.9, and somatic
rSO2 was 76.4  7.7 (P  .001). The risk of cerebral desaturation was significantly
increased after cardiopulmonary bypass.
Conclusions: Cerebral oxygenation was maintained during regional cerebral perfu-
sion at prebypass levels with deep hypothermia. However, after rewarming and sepa-
ration from cardiopulmonary bypass, cerebral oxygenation was lower compared with
prebypass or somatic values. These results indicate that cerebrovascular resistance
is increased after deep hypothermic cardiopulmonary bypass, even with continuous
perfusion techniques, placing the cerebral circulation at risk postoperatively.
Strategies to improve outcome after cardiopulmonary bypass (CPB)and circulatory arrest for complex congenital heart disease have beendirected at optimizing metabolic suppression and oxygen deliverywith adequate cooling time and pH-stat perfusion strategies,1,2 reduc-ing hemodilution3,4 and ischemia time,5 and preventing endothelialdysfunction and related injury.1,6-9 Near-infrared spectroscopy
(NIRS) has aided the study of regional perfusion by providing a noninvasive
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estimate of tissue oxyhemoglobin saturation.10-12 Continu-
ous regional cerebral perfusion (RCP) can provide blood
flow to the head during aortic arch reconstruction,13 and
maintenance of cerebral oxygen saturation during RCP has
been demonstrated with NIRS.12,14 However, delayed ab-
normalities in regional circulation may occur after deep
hypothermic CPB and deep hypothermic circulatory arrest
(DHCA) because of prolonged changes in cerebrovascular
function.15,16 We hypothesized that such alterations in re-
gional autoregulation, in combination with inadequate
global oxygen delivery post-CPB secondary to functional
and anatomic circulatory limitations,17 place tissues in se-
lective vascular beds at risk for ischemia.17-19 We used a
commercially available NIRS device to assess changes in
oxyhemoglobin saturation in two different regional circula-
tions (cerebral10,11,14 and thoraco-lumbar or somatic13,20)
before, during, and immediately after stage 1 palliation
(S1P) of hypoplastic left heart syndrome, hypothesizing that
continuous cerebral perfusion would preserve cerebral ox-
ygenation both during and after CPB.
Methods
Patients and Clinical Techniques
Nine patients undergoing stage 1 palliation for hypoplastic left
heart syndrome were studied. Institutional review board approval,
parental consent for administration of phenoxybenzamine, and
clinical physiologic data were obtained for all patients. Hypercap-
nia was used to control pulmonary blood flow and improve sys-
temic oxygen delivery as necessary before CPB.21 High-dose,
synthetic, opioid-based anesthesia with supplemental isoflurane
was induced in all patients, with opioid infusions maintained into
the postoperative period.22 Surgical repair was performed using
techniques previously described: relief of arch obstruction, ascend-
ing aorta-to-pulmonary artery trunk anastomosis, homograft aug-
mentation of the aortic arch, placement of a systemic-to-pulmo-
nary shunt, and creation of unrestrictive interatrial patency.23 CPB
was initiated through a synthetic shunt anastomosed to the innom-
inate artery using a Stockert SC roller pump (Sorin Biomedical,
Irvine, Calif) and a Dideco Lilliput 1 hollow fiber membrane
oxygenator (Cobe Cardiovascular, Arvada, Calif). CPB manage-
ment consisted of target flows of 2 to 4 L · m2 · min and hematocrit
25% to 30% with pH-stat blood gas management for uniform
cooling (18°C-20°C) at nasopharyngeal and bladder sites (mini-
mum time 30 minutes); continuous cerebral perfusion through the
innominate shunt at pump flows of 30 to 70 mL · kg · min13 during
neoaortic and arch reconstruction; and resumption of full support
at target flows of 3 to 4 L · m2 · min after somatic and cardiac
reperfusion, with a gradual switch to alpha-stat strategy and
hemoconcentration during rewarming to a target hematocrit of
35% or greater before separation from CPB. All patients received
aprotinin 1.7  106 KIU/m2 and methylprednisolone 10 mg/kg
before CPB, and phenoxybenzamine 0.25 mg/kg was added to the
pump prime. Separation from CPB occurred after initiation of
infusions of milrinone (0.5 g · kg1 · min1), dopamine (3 g ·
kg1 · min1), and epinephrine or norepinephrine (0.05-0.15 g ·
kg1 · min1) or both as needed to achieve an approximate
systemic vascular resistance index of 10 to 12 Wood units and
adequate contractility. Modified ultrafiltration was used in all
patients immediately after separation from CPB. Post-CPB hemo-
dynamic management included a primary target of SvO2 of 50% or
greater, including mean arterial pressure greater than 45 mm Hg,
SaO2 greater than 75%, and hematocrit greater than 40% as pre-
viously described.17 No alterations from standard treatment were
undertaken during the study period except to use rSO2 data to
guide RCP to a target of 75% or greater.
Monitoring and Data Acquisition
In all patients, blood pressure was invasively monitored with an
existing umbilical artery catheter, and atrial pressure was moni-
tored with an umbilical vein catheter if present or an atrial line
placed at the time of surgery. Arterial oxygen saturation was
monitored continuously in the lower extremity (Nellcor N200;
Pleasanton, Calif). Systemic venous oxygenation (SvO2) was mon-
itored continuously during CPB from the venous drainage
(Terumo CDI-500; Ann Arbor, Mich) and post-CPB using a 4FR
optical catheter (Abbott Oxycath; Abbott Laboratories, Abbott
Park, Ill) placed in the superior vena cava before separation from
CPB. Airway gas tensions were monitored using Raman spectros-
copy (Ohmeda Rascal-2, Louisville, Colo). Data from these
sources were captured on a clinical information system (GE/
Marquette Solar; Milwaukee, Wis) and trended at 5-minute inter-
vals. NIRS probes were placed on the patient’s midline forehead
(cerebral) and slightly to the right of midline on the T10-L2
posterior flank (somatic) after entry into the operating room. The
probes were monitored by a dual-detector device (Somanetics
INVOS 5100A, Troy, Mich) and trended at 1-minute intervals.
CPB flows, temperatures, and pressures were captured at 5-minute
intervals. Arterial and venous blood gases were obtained at clini-
cally appropriate intervals, with tensions reported at 37°C (Radi-
ometer ABL, Copenhagen, Denmark).
Statistical Analysis
Prospective, electronically captured, and manually recorded data
were inserted into a common statistical database. In addition to
measured variables, derived variables were calculated as follows:
organ perfusion pressure (PP)  mean arterial blood pressure 
central venous pressure; cerebral Da-rO2 SaO2 cerebral rSO2;
somatic Da-rO2  SaO2  somatic rSO2; DrSO2 (cerebral-so-
matic)  cerebral rSO2  somatic rSO2; oxygen content PP index
(CaO2  PPI) 1.34  hemoglobin  PP. Each patient’s clinical data
were divided into 5 major time periods consisting of 11 intervals,
demarcated by preinduction baseline, anesthesia induction, surgi-
cal incision, initiation of CPB, initiation of myocardial ischemia
with aortic crossclamp, initiation of RCP, resumption of CPB,
removal of aortic crossclamp, separation from CPB, completion of
modified ultrafiltration, and surgical closure. Within each interval
for each patient, data were collapsed into 5 epochs of equal
duration to create 55 distinct epochs for subsequent statistical
analysis. Data were summarized within intervals and periods, and
presented as mean  SD if continuous and number and percent if
discrete, with 95% confidence intervals (CIs) calculated as appro-
priate. Generalized least squares regression and analysis of vari-
ance (ANOVA) techniques were used to account for repeated
measurements within patients and time intervals. Data were com-
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pared across time periods or intervals by 2-sided t tests on regres-
sion coefficients or by 2-way analysis of variance for repeated
measures for comparisons of means and by the likelihood-ratio test
for risk comparisons, with significance cutoff at P  .05 after
correction for multiple comparisons by the Bonferroni method. All
calculations were performed with a standard statistical package
(STATA version 8; Stata Corp, College Station, Tex).
Results
Demographic and baseline clinical data from the 9 patients
are summarized in Table 1. All patients underwent S1P and
survived to hospital discharge; 3176 minutes of data were
available for analysis (353 min/patient, range 304-418 min-
utes). Hypothermic RCP was accomplished in all patients at
a flow rate of 47  22 mL · kg1 · min1 (75  35 mL ·
m2 · min1).
Regional saturation data differed markedly during peri-
ods of perfusion and surgical repair. Preincision baseline
cerebral rSO2 was 68%  4% until CPB, and baseline
somatic rSO2 was 68%  8%, decreasing to 56%  14%
before CPB. During cooling on CPB, cerebral rSO2 in-
creased to 87%  8%, and somatic rSO2 increased to 77%
 13%. During RCP, cerebral rSO2 was maintained at 81%
 9%, whereas somatic rSO2 decreased to 41%  7%,
recovering to 77%  10% and 84%  13%, respectively,
during rewarming on CPB. After separation from CPB,
regional saturation in both measured beds decreased; cere-
bral rSO2 decreased progressively to 48%  7%, whereas
the somatic rSO2 decreased but remained above baseline at
78%  4%. A summary of regional saturations at major
time periods is contained in Table 2. Cerebral and somatic
rSO2 were different from each other and from baseline
values at all time points (P  .001). Detailed regional
saturation data are shown in Figure 1.
The post-CPB decrease in cerebral rSO2 was not solely
caused by the reduction in SaO2. Figure 2 shows the SaO2,
regional SaO2  rSO2 difference, and cerebral-somatic
rSO2 difference by time period. These data show that re-
gional cerebral oxygen extraction, as approximated by the
SaO2  rSO2 difference, was increased in the post-CPB
period relative to somatic beds. The decrease in cerebral
rSO2 occurred despite increases in hematocrit, CO2 tension,
and mean arterial pressure after separation from CPB, all of
which would be expected to favor increases in cerebral
blood flow and oxygen delivery. Other potential determi-
nants of cerebral oxygenation such as temperature, pump
flow rate, isoflurane concentration, and the CaO2 PPI, an
index of regional oxygen availability, also were maintained
in the period after separation from CPB. Complete hemo-
dynamic data are detailed in Table 3.
The relationship between cerebral rSO2 and potential
determinants (mean arterial blood pressure, central venous
pressure, SaO2, PaCO2, temperature, hematocrit, and isoflu-
rane concentration) were evaluated in a multiple linear least
squares regression model, comparing all data before and
after CPB. The model significantly related the independent
variables to cerebral rSO2 (r2  0.79), and several param-
eters were significantly different pre- and post-CPB. The
complete model parameters are shown in Table 4.
The risk of regional desaturation was assessed during
each period as the proportion of time with rSO2 less than
50%. The overall risks of such cerebral and somatic desatu-
ration were 11% and 23%, respectively. Somatic rSO2 was
threatened after incision (risk 42%, CI 36%-48%, P  .001
compared with baseline) and improved during CPB. During
RCP, the somatic rSO2 was below the threshold 89% of the
time (CI 84%-92%, P  .001 compared with baseline), but
the risk of somatic desaturation was essentially zero after
separation from CPB. In contrast, the risk of cerebral de-
saturation was minimal until separation from CPB, when it
was 21% (CI 16%-28%, P  .001 compared with baseline),
and continued to increase after withdrawal of volatile anes-
thesia to 74% (CI 60%-85%, P  .001 compared with
baseline). These findings are shown in Figure 3.
Discussion
The major findings of this study were that cerebral rSO2
decreased post-CPB despite continuous RCP, and that as-
sessment of 2-site regional oxygenation using NIRS tech-
TABLE 2. Regional saturations at major time periods
Time period Cerebral rSO2 (%) Somatic rSO2 (%)
Pre-CPB 65.4 8.9 (63.2-67.6) 58.9 12.4 (57.8-59.9)†
CPB (cooling) 87.2 7.8 (85.0-89.5)* 77.2 12.5 (75.6-78.8)*†
RCP 80.7 8.6 (78.6-83.0)* 41.4 7.1 (39.9-42.8)*†
CPB (warming) 76.8 10.2 (74.6-79.0)* 83.5 12.9 (82.2-84.8)*†
Post-CPB 53.2 14.9 (51.0-55.5)* 76.4 7.7 (75.3-77.6)*†
Regional saturation data summarized within major operative periods. Data
are presented as mean  SD and (95% confidence intervals). All differ-
ences are significant at P  .001 by repeated measures ANOVA.
*Differences compared with pre-CPB baseline.
†Differences between sites.
TABLE 1. Demographic data
Characteristic
Age (d) 4.9 1.7
Weight (kg) 2.84 0.59
BSA (m2) 0.179 0.038
Preoperative Hgb (g/dL) 40 5
Preoperative SpO2 (%) 89 3
Preoperative mechanical ventilation 6/9 (67%)
Preoperative inotropes 5/9 (55%)
CPB duration (min) 113 12
RCP duration (min) 58 10
Data are presented as mean  SD or number (%).
BSA, Body surface area; Hgb, hemoglobin; CPB, cardiopulmonary bypass;
RCP, regional cerebral perfusion.
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nology provided information about oxygen delivery distinct
from global measures. The dual-path length device that was
used measures average hemoglobin saturation in a slice of
tissue approximately 1.5 to 2.5 cm deep, tracks changes in
jugular venous saturation closely, and detects changes in
tissue oxygenation in a variety of tissues.13,24,25 Although
no formal calculations of regional blood flow were made in
this study, cerebral rSO2 has been shown to closely track
changes in jugular venous saturation (r2  0.91), and thus
changes in rSO2 can estimate regional flow-metabolism
relationships.26 We attempted to place somatic probes to
capture the renal circulation (which normally has a low
extraction ratio but is under intense sympathetic control) as
a contrast with the cerebral circulation (which normally
exhibits intense perfusion-metabolism coupling). This was
performed to serve as a within-patient control for factors
such as changes in venous volume and to help differentiate
changes in global systemic flow from changes in the distri-
bution of regional flows as potential causes of changes in
cerebral rSO2.
Interventions to increase cerebral rSO2 may reduce neu-
rologic morbidity in children undergoing CPB.27,28 Al-
though absolute thresholds of rSO2 for neurologic injury are
not known in human neonates, evidence from adult hu-
mans29 and neonatal piglets30 indicates that aerobic metab-
olism is impaired when cerebral rSO2 decreases below 44%
to 47%. Critically low values for cerebral rSO2 have been
reported preoperatively in neonates with a variety of con-
genital lesions31 and were observed with substantial fre-
quency in our patients in the post-CPB period.
The pre-CPB rSO2 data revealed a normal cerebral arte-
rial-regional saturation difference31 but an increased so-
matic arterial-regional difference, typical of a “stressed”
patient with increased resistance in vascular beds subject to
regional sympathetic control, with resultant redistribution of
systemic perfusion from splanchnic to cerebral circulations.
The baseline hemodynamic data in these infants revealed
high SaO2 and high pulmonary and systemic flow ratios
despite preoperative management with hypercapnia and low
FIO2; thus, compromised splanchnic and somatic flow were
expected.
Before CPB, SvO2 was slightly lower than cerebral rSO2,
reflecting the contribution of relatively desaturated somatic
blood to SvO2. After CPB, the converse was true; SvO2 was
higher than cerebral rSO2, reflecting the contribution of
more well-saturated somatic blood to SvO2. These findings
emphasize the differences between regional and global mea-
sures of oxygen supply and demand relationships.18,32
The observed divergence of cerebral from somatic rSO2
post-CPB was expected,33 although the decrease in cerebral
rSO2 from the pre-CPB baseline indicates that cerebral
oxygenation may be vulnerable despite palliation of the
circulation through S1P. The reasons for the reduction in
cerebral rSO2 from baseline include (1) reduced global
oxygen delivery, (2) reduced somatic and splanchnic resis-
tance, (3) increased cerebral resistance, and (4) changes in
the venous blood compartment.
Although global oxygen delivery (SvO2) was not rou-
tinely assessed preoperatively, SvO2 was maintained after
separation from CPB until closure. Similarly, the CaO2 
PPI, a measure of regional oxygen availability, was main-
tained post-CPB. Thus the decrease in cerebral rSO2 post-
CPB was not likely explained by a reduction in global
oxygen delivery. However, because previous data have de-
scribed the occurrence of decreasing SvO2 in the first 6 to
12 hours postoperatively,34 a reduction in global oxygen
delivery may increase the risk of cerebral desaturation in the
later postoperative period.
A reduction in splanchnic and somatic resistance by
reactive hyperemia, phenoxybenzamine, milrinone, and
Figure 1. Cerebral and somatic rSO2 during repair. Repair was divided into 5 major periods consisting of 11
intervals as described. Data are shown as mean and SD for each epoch. CPB, Cardiopulmonary bypass; RCP,
regional cerebral perfusion. Dotted line marks preinduction baseline values.
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isoflurane likely contributed to the low risk of somatic
desaturation in the immediate post-CPB period. Alpha-ad-
renergic mechanisms of vasoconstriction are more active in
splanchnic, muscle, and skin beds than in organs with
intense autoregulation such as brain and heart.35-37 There-
fore, alpha-adrenergic blockade would be expected to re-
duce the sympathetically mediated increase in somatic re-
sistance that occurs in the patient post-CPB with reduced
Figure 2. SaO2, cerebral-somatic DrSO2, cerebral Da-rO2, and somatic Da-rO2 are shown during repair, presented
as mean and SD for each epoch. Dotted lines mark baseline measures for each parameter. CPB, Cardiopulmonary
bypass; RCP, regional cerebral perfusion.
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oxygen delivery. Our findings provide direct evidence for an
effect of phenoxybenzamine to preserve perfusion in so-
matic beds. However, the cerebral circulation may be more
vulnerable if splanchnic vasoconstriction is pharmacologi-
cally limited. Further study is necessary to quantify the
potential effect of phenoxybenzamine to redistribute blood
flow away from the cerebral circulation.
The decreased cerebral rSO2 corresponded in time to a
decrease in isoflurane concentration; isoflurane decreases
both cerebral oxygen consumption and cerebrovascular re-
sistance, with a resultant increase in cerebral oxygenation.38
Although isoflurane similarly alters autoregulation in all
systemic beds by its vasodilatory effects, additional somatic
vasodilation may not have occurred in the presence of
phenoxybenzamine and milrinone. Thus, the effect of
isoflurane to increase cerebral blood flow may be enhanced
in the presence of additional pharmacologic reduction in
somatic resistance.
Cerebral resistance is increased after hypothermic circu-
latory arrest and hypothermic CPB.1,5,15 This may occur as
result of altered dynamic autoregulation from changes in
PCO2 and pH as a result of impaired autoregulation,15,16
TABLE 3. Complete hemodynamic data
Parameter Baseline Induction Incision CPB AoX
Duration (min) 19 7 21 6 74 12 42 9 4 2
rSO2 cerebral (%) 68 4 64 10 65 9 88 8 87 8
rSO2 somatic (%) 68 8 62 6 56 14 78 13 69 19
SaO2 (%) 90 3 90 4 91 5 99 2 99 2
SvO2 (%) @ @ 63 14 @ 93 7 92 4
Temperature (centigrade) 37.2 0.2 37.1 0.3 35.3 1.6 21.5 4.2 18.9 1.4
Hematocrit (%) 41 5 41 6 41 5 25 2 26 3
MABP (mm Hg) 48 4 46 6 42 7 32 9 18 5
CVP (mm Hg) 9 4 9 4 9 4 3 3 4 2
PP (mm Hg) 40 5 38 5 34 5 30 8 15 4
FIO2 0.22 0.01 0.22 0.01 0.24 0.05 0.43 0.06 0.47 0.08
PaCO2 (torr) 44 7 51 8 50 10 43 11 47 13
PetCO2 (torr) 45 5 46 8 47 12
Isoflurane (%) 0.23 0.09 0.25 0.09 0.27 0.13 0.49 0.07 0.47 0.08
CPB flow (mL · kg1 · min1) 195 62 103 47
CPB flow (L · m2 · min1) 3.11 0.99 1.65 0.70
Da-rO2 cerebral (%) 21 9 26 11 26 10 11 9 12 8
Da-rO2 somatic (%) 22 6 30 9 36 17 22 13 31 20
DrSO2 cerebral-somatic 1 6 3 5 6 10 12 13 20 19
CaO2  PP index 658 106 628 145 573 115 322 94 168 46
Detailed hemodynamic data at each of the 11 identified intervals presented as mean  SD. Cells with incomplete data are signified by @.
MABP, Mean arterial blood pressure; CVP, central venous pressure; PP, perfusion pressure; AoX, aortic crossclamp; MUF, modified ultrafiltration.
TABLE 4. Effect of CPB on determinants of cerebral rSO2
Parameter
Pre-CPB
coefficient P value
Post-CPB
coefficient P value
P value for
difference
MABP (mm Hg) 0.14 0.05 .002 0.43 0.07 .001 .001
SaO2 (%) 0.19 0.05 .001 0.19 0.05 .001 —
CVP (mm Hg) 0.14 0.06 .026 0.14 0.06 .026 —
Hematocrit (%) 1.39 0.03 .001 1.14 0.07 .001 .001
PaCO2 (torr) 0.38 0.03 .001 0.80 0.05 .001 .001
Temperature (centigrade) 0.7 0.11 .001 4.65 0.32 .001 .001
Isoflurane (%) 21.5 1.33 .001 26.1 1.5 .001 .001
Constant 106.5 8.3 .001 106.5 8.3 .001 —
Table shows the coefficients for parameters that were significantly related to cerebral rSO2 in a GLS regression model using all pre- and post-CPB data
points (N  2390). Parameter coefficient shows change in rSO2 for unit change in parameter. Model R
2 was 0.75 within patient, 0.89 between patients, and
0.79 overall. P value for difference compares pre-CPB with post-CPB coefficient. The effects of MABP, hematocrit, PaCO2, temperature, and isoflurane
concentration were significantly altered by CPB.
GLS, Generalized least square.
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endothelial dysfunction,3,6,8,9 tissue edema, microvascular
occlusion, cerebral edema, or other mechanical factors. Per-
fusion at excessive pressure has been implicated in the
cerebrovascular lesion induced by hypothermic CPB.12,16,39
Although we targeted a cerebral rSO2 greater than 75%
during RCP, we did not systematically reduce flow rates in
patients with cerebral rSO2 greater than 90%. Although the
RCP flows in our patients were in the same range (25-75 mL
· kg · min) as reported by others,12-14,39,40 excessive flow
during RCP may also contribute to the increased cerebro-
vascular resistance seen after hypothermic CPB. A target of
cerebral rSO2 or jugular bulb saturation greater than 90%
during CPB cooling, as in preparation for DHCA,5 thus may
not be advisable if RCP will be used.
The use of a pH-stat perfusion strategy, although en-
hancing recovery of cerebral energetics41 if post-CPB PP
is controlled, may contribute to this overperfusion lesion
through alteration of cerebral autoregulation.16,42 Our
results indicate that hypercapnia during pre-CPB man-
agement and pH-stat CPB management may reset cere-
brovascular autoregulation for CO2 to a higher level. The
enhanced sensitivity of rSO2 to changes in PP and CO2
post-CPB (Table 4) is consistent with altered autoregu-
lation.16 The increased dependency of the cerebral circu-
lation on PP constitutes a physiologic risk in the patient
with parallel circulation, because increases in systemic
blood pressure and SVR will reduce systemic blood
flow.43 On the other hand, CO2 responsiveness was en-
hanced post-CPB in our patients, indicating that more
aggressive use of hypercapnia may improve cerebral
rSO2 even in the face of adequate global oxygen delivery
measures.
Our findings emphasize the direct effect of hypothermic
CPB and RCP on cerebrovascular resistance11,16,41 despite
efforts to optimize regional oxygen delivery,44 including
adjuncts to minimize the endothelial dysfunction from
CPB.6,8,9 Modifications in perfusion strategy to limit
changes in rSO2 may provide a means to avoid both supply-
dependent oxygen conditions40 and overperfusion during
hypothermia.12 Use of more moderate hypothermia during
CPB and RCP may be justifiable under regional rSO2 guid-
ance to reduce the alterations in cerebral resistance that
result from deep hypothermia. However, the relationship
between the effects of DHCA and hypothermic RCP on
cerebral blood flow and metabolism, and any subsequent
neurologic injury, is still unclear.
The cerebral circulation remains at risk post-CPB de-
spite continuous cerebral perfusion, and neurologic dys-
function may result from postoperative cerebral ischemia
independently of CPB techniques. Our results indicate
that extended monitoring of brain oxygenation in the
immediate postoperative period, when reduced global
oxygen delivery is likely to be superimposed on in-
creased cerebrovascular resistance, may reveal further
opportunities for hemodynamic interventions to reduce
the risk of cerebral ischemia.
RCP CPB AoX off Off CPB
MUF
performed Closure
Overall
total
58 10 7 5 59 9 19 5 61 12 11 8 353 39
81 9 76 15 77 10 56 7 52 9 48 7 70 15
41 7 56 17 86 8 79 8 76 7 78 4 67 18
98 4 97 5 95 8 83 3 82 4 81 3 92 8
89 8 76 17 79 13 63 6 61 6 62 4 77 16
19.6 2.9 20.5 3.2 32.1 5.1 35.2 2.2 36.1 0.7 36.5 0.5 30 8
27 3 31 6 32 4 38 4 42 3 45 3 35 8
17 8 27 9 44 8 49 4 53 3 52 3 39 14
4 2 3 2 6 4 10 3 11 2 10 2 7 4
13 8 24 9 38 9 38 6 42 4 42 4 32 12
0.51 0.14 0.53 0.17 0.64 0.22 0.62 0.20 0.51 0.10 0.51 0.14 0.45 0.20
41 8 41 6 39 4 40 3 42 5 46 6 44 9
15 14 29 5 32 6 35 5 27 19
0.51 0.06 0.49 0.09 0.52 0.08 0.34 0.21 0.28 0.21 0.04 0.07 0.38 0.17
46 22 111 68 214 49 70 9
0.74 0.35 1.75 1.06 3.41 0.77 1.1 1.5
17 11 21 13 17 13 28 8 30 9 33 8 22 12
59 7 44 17 10 10 6 9 6 9 2 2 25 22
42 10 27 22 8 14 24 13 21 13 27 7 3.1 24
153 100 312 94 529 210 556 145 652 110 679 87 474 224
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Discussion
Dr Gil Wernovsky (Philadelphia, Pa). I found this study to be
quite innovative, well designed, and thoughtfully presented. It adds
to the growing body of information on the complexities of single
ventricle physiology, both before and after CPB.
In the past 15 years, there have been consistent and incremental
improvements in the outcomes for children undergoing stage 1
reconstruction, and many things have changed because of our
clinical experience and laboratory findings.
These include changes in the methods of preoperative stabili-
zation, the timing of surgery (as you have described in regard to
the institution of CPB, including a shift to RCP to avoid DHCA),
and the medical management of these patients, with increasing use
of postoperative, long-acting vasodilators (such as phenoxyben-
zamine) and frequent postoperative monitoring. Many of these
advances have been pioneered by your group in Milwaukee and
others in this room.
On the basis of these studies, there has been a shift at many
centers to embrace these new practices. However, before this
report, there has been little information presented on the potential
neurologic morbidities of two of these changes—RCP and the
routine use of phenoxybenzamine.
This article contains a substantial amount of data, but I want to
comment on two points and then ask Dr Hoffman three questions.
On the basis of clinical laboratory data from a decade ago,
many in our field have moved to avoid circulatory arrest whenever
possible. However, a similar detailed assessment of this alterna-
tive, RCP in the human, is lacking.
The strategy of RCP for an average of approximately 1 hour in
this study, which was preceded by bypass of approximately 45
minutes, and another period of 20 minutes or so after the period of
RCP, was associated with estimates of adequate cerebral oxygen
delivery by NIRS during the procedure, but significantly lower
values after the procedure. As the authors state, this was not solely
the result of a postoperative decrease in arterial oxygen saturation,
but most likely the result of the increased postoperative cerebral
vascular resistance caused by impaired autoregulation.
In addition, the patients received a potent systemic vasodilator
(phenoxybenzamine) to minimize ventricular afterload.
Thus, following these combined strategies, a situation has been
created that conspires to maximally shunt blood away from the
central nervous system, high cerebrovascular resistance and low
splanchnic resistance.
Now, this may or may not have clinical implications, and we
just do not know yet. It is important to emphasize that NIRS is a
surrogate variable for CNS oxygenation, and these observations
must be followed up with clinical studies to determine the clinical
relevance in the long term.
So I would like to ask the following three questions. First, the
authors state that the rate of RCP was titrated during the procedure
over a wide range (I believe it was 30-70 mL · kg · min) to achieve
a target cerebral saturation of 75% or greater during the procedure.
Did you look at whether the decrease in postoperative cerebral
oxygenation was related at all to the absolute rate or pressure of the
cerebral blood flow that you used? One could hypothesize that
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higher flow rates or pressure during profound hypothermia could
cause more endothelial damage and impaired autoregulation.
Second, the model that related regional cerebral saturation to
the hemodynamic and bypass parameters was elegant and very
interesting. The authors found that RCP, treatment with phenoxy-
benzamine, and a number of potentially modifiable parameters
were related to lower cerebral oxygen saturations, including mean
arterial pressure, lower hematocrit, and, I think, higher tempera-
ture.
Earlier in the session, Dr Gaynor presented data showing in a
more heterogenous group of children that low diastolic pressure in
the coronary intensive care unit was related to an increased inci-
dence of periventricular leukomalacia.
Have you looked at the cerebral oxygenation data in the post-
bypass period in terms of diastolic pressure in addition to mean
arterial pressure, because this could be particularly low in patients
with a diastolic runoff through the shunt?
Finally, if you brought this methodology into the intensive care
unit, because, as your group has shown, the real vulnerable period
is 6 to 12 hours later, would the cerebral somatic difference persist
into the postoperative period?
You and your group are really to be commended for continuing
to investigate the implications of the changes in our strategies and
to provide us with real data rather than dogma as we move
forward.
Dr Hoffman. I agree that spectroscopy measurements are
surrogate outcome indicators. I anticipate that with collaboration
from colleagues we will be able to answer your most important
question: What does this have to do with the relationship between
NIRS measures and subsequent neurologic outcome?
With regard to the potential conspiracy of afterload reduction
and posthypothermic CPB-increased cerebrovascular resistance, I
agree that this is a major caveat and find these data compelling
indication for regional saturation monitoring in this population.
The controversial question that we didn’t answer, because we
have largely abandoned the use of total circulatory arrest, is
whether the increase in cerebrovascular resistance after DHCA is
greater or less than that observed with the continuous RCP tech-
niques.
Your first question related to the effect of perfusion flow rates
on changes in cerebrovascular resistance.
I could not do the analysis that you suggested. In actuality, the
perfusion flow rates vary somewhat in response to surgical ma-
nipulations on a minute-to-minute basis; our data collection tech-
nique did not allow the degree of bypass flow tracking to enable
the data analysis required to answer your question, so I would have
to think about the methodology.
However, there are good data showing that overperfusion,
either by pressure or flow, increases the cerebrovascular lesion
seen after deep hypothermic CPB.
We typically, as I think other centers do, try to overflow with
a pH-stat cooling strategy to achieve a jugular venous saturation or
regional NIRS saturation greater than 90% in anticipation of a
potential period of cerebral circulatory arrest. I’m not sure that
overperfusion is routinely necessary anymore if NIRS monitoring
and continuous cerebral perfusion are used, and it may be that
overperfusion is contributing to things.
You wondered about the effects of postoperative diastolic
blood pressure and global hemodynamic vulnerability on cerebral
perfusion. I certainly agree that the first 6 to 24 postoperative hours
is the most vulnerable, critical period for these patients. We have
some NIRS data for this time period, but it has not been analyzed.
Because of the anticipated postoperative vulnerability, we hope
to use this technology in most postoperative patients. We’re cur-
rently limited by the number of available devices, as most inves-
tigators are.
Dr Carlos Troconis (Caracas, Venezuela). Dr Hoffman, are
we looking at the tip of an iceberg? Is the problem more profound?
Should we look back into the cerebral fetal circulation in hypo-
plastic left heart syndrome? We will probably find many reports
about the incidence of microcephaly with this syndrome and
undeveloped microcirculation or high resistance in cerebral flow.
Can you make comments on that?
Dr Hoffman. I don’t know about confounding anomalies of
cerebrovascular anatomy in these patients. We have to deal with
what we get. We can’t change who comes to us. Preoperative
management is important and has obvious implications for re-
gional perfusion, and for most people in the room, there is prob-
ably less control over that than the immediate perioperative man-
agement.
Certainly the Philadelphia group has detected profound cere-
bral desaturation in a diverse group of cardiac neonates preoper-
atively. We didn’t see that here. We observed relatively normal
arterial-to-brain saturation differences in these patients preopera-
tively, indicating adequate cerebrovascular development but the
potential for wide ranges of cerebral flow related to differences in
preoperative management. So the potential certainly exists.
We have the advantage of extensive monitoring during a very
intense period of operative intervention, but, as you pointed out,
the horse could leave the barn before we get to the operating room,
or, as Dr Wernovsky anticipated, sometime afterward.
Dr Richard A. Jonas (Boston, Mass). I have a question about
the positioning of your oximetrics catheter and wonder if it was
truly in the jugular bulb. If it was in the superior vena cava, then
you were looking at a mix of jugular venous blood and somatic
venous blood. And I very much doubt your speculation that the
decrease in saturation is not likely to be caused by reduced cerebral
oxygen delivery.
You have proposed that there is an increase in cerebrovascular
resistance, which presumably reduces cerebral blood flow and
cerebral oxygen delivery.
In fact, what I would suggest is that it is very likely that
cerebral blood flow, and therefore oxygen delivery, is decreased
related to the position of the shunt. I believe you have created a steal
from the cerebral circulation. I am going to be fascinated to see you
repeat the study, which I’m sure you will, when you perform the right
ventricle to pulmonary artery shunt. I believe this will show quite a
different result relative to what you presented today.
I think cerebral blood flow might also be decreased because of
increased cerebrovascular resistance related to edema, secondary
to your use of regional perfusion.
And incidentally, if I could make a plea, RCP has been the
abbreviation for retrograde cerebral perfusion, and we are really
going to have to come up a different acronym for RCP, otherwise
the literature is going to get very confusing.
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In conclusion, until we have some mechanism for monitoring
the adequacy of cerebral flow or excessive flow, you run a real risk
of causing cerebral edema with regional perfusion. So that might
be an additional cause for reduced cerebral blood flow. But I’m
interested in the catheter position you used.
Dr Hoffman. The superior vena cava catheters are placed ap-
proximately 1 cm above the superior vena cava-right atrial junction,
and we attempted to thread this up to the jugular bulb in only 1 patient.
So yes, the superior vena cava saturation is not the same as
cerebral NIRS saturation. We do have data relating those two,
which will be presented subsequently.
I think your point about the innominate take-off and potential
cerebral steal is true, and it will be interesting to compare this
cerebral NIRS data with patients who derive pulmonary blood flow
from a right ventricular shunt.
The point I was trying to make about oxygen delivery was that
whole-body oxygen delivery was not decreased. Therefore I agree
completely that this decreased cerebral saturation we observed
post-CPB is likely caused by decreased cerebral oxygen delivery
related to regional resistance changes.
Dr Ross M. Ungerleider (Portland, Ore). On this basis, have
you changed your postoperative strategy at all?
I mean, it seems that the most simple and straightforward thing
you could do would be to keep PCO2 higher as you come off
bypass, and PCO2 is related to cerebral blood flow. And in the face
of the runoffs you are talking about (that you can’t really do very
much about it), it would seem that it might modify this. Have you
tried that?
Dr Hoffman. We have used this device in a number of patients,
and the effect of CO2 is immediate and apparent to anybody who
bothers to look.
So yes, we have used more hypercapnia, as others have sug-
gested, with the advantage of regional oxygenation data to guide
this strategy.
Hoffman et al Surgery for Congenital Heart Disease
The Journal of Thoracic and Cardiovascular Surgery ● Volume 127, Number 1 233
CH
D
